Cardiovascular risk profiles of GnRH agonists and antagonists: real-world analysis from UK general practice

PURPOSE: Androgen deprivation therapy (ADT) is the mainstay for the management of metastatic prostate cancer. Available pharmaceutical ADTs include gonadotropin-releasing hormone (GnRH) agonists and antagonists. Here, real-world data are presented from the UK general practitioner Optimum Patient Car...

Descripción completa

Detalles Bibliográficos
Autores principales: Davey, Patrick, Kirby, Mike G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Topic Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910366/
https://www.ncbi.nlm.nih.gov/pubmed/32979057
http://dx.doi.org/10.1007/s00345-020-03433-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910366/
https://www.ncbi.nlm.nih.gov/pubmed/32979057
http://dx.doi.org/10.1007/s00345-020-03433-3

Ejemplares similares